Is Inovio Pharmaceuticals Stock a good buy in 2023, according to Wall Street analysts?
The consensus among 1 Wall Street analyst covering (NASDAQ: INO) stock is to Hold INO stock.
Out of 1 analyst, 0 (0%) are recommending INO as a Strong Buy, 0 (0%) are recommending INO as a Buy, 1 (100%) are recommending INO as a Hold, 0 (0%) are recommending INO as a Sell, and 0 (0%) are recommending INO as a Strong Sell.
What is INO's forecast return on equity (ROE) for 2023-2026?
(NASDAQ: INO) forecast ROE is N/A, which is considered weak.
What is INO's Price Target?
According to 1 Wall Street analyst that have issued a 1 year INO price target, the average INO price target is $2.00, with the highest INO stock price forecast at $2.00 and the lowest INO stock price forecast at $2.00.
The Wall Street analyst predicted that Inovio Pharmaceuticals's share price could reach $2.00 by May 11, 2024. The average Inovio Pharmaceuticals stock price prediction forecasts a potential upside of 423.56% from the current INO share price of $0.38.
What is INO's forecast return on assets (ROA) for 2023-2026?
(NASDAQ: INO) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of -0.11%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.